Now accepting Telehealth appointments. Schedule a virtual visit.

‘AeroNabs’ A New Inhalable Protection Against Our Current Pandemic?

stuff animal

A team of scientists at UCSF has engineered a completely synthetic molecule that straitjackets the critical SARS-CoV-2 machinery that allows the virus to infect our cells causing the current pandemic.  This new technology will be a game-changer in halting the spread of COVID-19, as researchers around the world are working on finding a safe and effective vaccine.  Details of the research report are in a new paper, now available on the preprint server bioRxiv.  

The treatment called "AeroNabs" is an aerosolized formulation that will be in the form of a nasal spray or inhaler to be used once daily.  Since it is a nasal spray or inhaler, it can be self-administered easily.  AeroNabs could provide powerful protection against COVID-19 until a vaccine becomes available, or it can be used in conjunction with a vaccine.  Clinical trials will be underway soon and the researchers hope to make it readily available to the public as an inexpensive preventative treatment for COVID-19. 

AeroNabls will be an effective molecular form of PPE that could serve as a powerful and reliable line of defense against COVID-19 used together with physical PPE and social distancing and wearing masks to decrease transmission of the virus.

For more tips about your GI health, nutrition advice, or treatment for your chronic condition, contact us at one of our offices in San Ramon located in the East Bay which is easily accessible from the San Francisco and Pennisula or Turlock, which is located in the Central Valley.  Request an appointment with Dr. Mark online today or call our office.




Dr. Frances Mark, Pharm.D.

You Might Also Enjoy...

What you should know about Mercury Amalgam Removal

Recent guidelines have changed from the FDA regarding mercury amalgam removal. We review what safe removal should look like. If you elect for removal you also need detoxification to prepare before, during and afterwards.

What you should know about Eosinophilic Esophagitis

One in two thousand people across the globe have a gastrointestinal immune related condition where they may have trouble swallowing called eosinophilic esophagitis. Here is what you should know and what we can do to help.

Vaccine Update and NovaVax

Novavax shows promise in UK and South African Phase 3 trial numbers so are. We are closer to getting Johnson and Johnson's vaccine in the U.S. Variants are a big wildcard for the current vaccine programs.

BioSpore for SIBO

In Small Intestinal Bacterial Overgrowth or SIBO, fermentation increases in the small intestine, so even healthy diets can cause gas, bloating and intolerance to certain foods and probiotics. Here is an illustration of how BioSpore can help.